Molecular characterization of diffuse large B‐cell lymphomas associated with hepatitis C virus infection
Roberta Sciarra,Michele Merli,Caterina Cristinelli,Marco Lucioni,Silvia Zibellini,Roberta Riboni,Daniela Furlan,Silvia Uccella,Caterina Zerbi,Benedetta Bianchi,Manuel Gotti,Virginia Valeria Ferretti,Chiara Varraso,Sara Fraticelli,Tanja Lazic,Irene Defrancesco,Barbara Mora,Laura Libera,Alessandro Mazzacane,Federico Carpi,Martha Berliner,Giuseppe Neri,Ettore Rizzo,Federica De Paoli,Fausto Sessa,Francesco Passamonti,Marco Paulli,Luca Arcaini,Federica De Paoli
DOI: https://doi.org/10.1111/bjh.19378
2024-03-07
British Journal of Haematology
Abstract:The comprehensive genetic landscape of hepatitis C virus (HCV)‐associated diffuse large B‐cell lymphoma (DLBCL) has been investigated on a cohort of 54 patients by multiple molecular assays. FISH analysis showed rearrangements involving BCL6 in about 52% of cases, MYC in 13%, and BCL2 in 4%. Lymph2Cx‐based assay recognized 42% of cases each as ABC and GCB, while 6 resulted unclassified. The most frequently mutated genes by next‐generation sequencing (NGS), that seem to be specific for HCV‐associated DLBCL were SETD1B (31%), RERE (28%), TBL1XR1 (26%), BCL11A (24%) and ZFP36L1 (19%). Cluster analysis by LymphGen classified 25.9% of cases as BN2, 13% as ST2 and 7.4% each as MCD and EZB. Overall, these results indicate a preferential marginal zone origin for a consistent subgroup of HCV‐associated DLBCL cases. Summary Hepatitis C virus (HCV)‐associated diffuse large B‐cell lymphoma (DLBCL) displays peculiar clinicopathological characteristics, but its molecular landscape is not fully elucidated. In this study, we investigated the clinicopathological and molecular features of 54 patients with HCV‐associated DLBCL. The median age was 71 years. An underlying marginal zone lymphoma component was detected in 14.8% of cases. FISH analysis showed rearrangements involving BCL6 in 50.9% of cases, MYC in 11.3% and BCL2 in 3.7%. Lymph2Cx‐based assay was successful in 38 cases, recognizing 16 cases (42.1%) as ABC and 16 cases as GCB subtypes, while six resulted unclassified. ABC cases exhibited a higher lymphoma‐related mortality (LRM). Next‐generation sequencing analysis showed mutations in 158/184 evaluated genes. The most frequently mutated genes were KMT2D (42.6%), SETD1B (33.3%), RERE (29.4%), FAS and PIM1 (27.8%) and TBL1XR1 (25.9%). A mutation in the NOTCH pathway was detected in 25.9% of cases and was associated with worst LRM. Cluster analysis by LymphGen classified 29/54 cases within definite groups, including BN2 in 14 (48.2%), ST2 in seven (24.2%) and MCD and EZB in four each (13.8%). Overall, these results indicate a preferential marginal zone origin for a consistent subgroup of HCV‐associated DLBCL cases and suggest potential implications for molecularly targeted therapies.
hematology